The metabolic syndrome in overweight epileptic patients treated with valproic acid.
about
The use of psychiatric drugs and worsening body mass index among inpatients with schizophreniaComparison of the metabolic syndrome risk in valproate-treated patients with epilepsy and the general population in Estonia.Antiepileptic drugs and markers of vascular riskValproic Acid as a potentiator of metabolic syndrome in institutionalized residents on concomitant antipsychotics: fat chance, or slim to none?Possible association between moderate intellectual disability and weight gain in valproic acid-treated patients with epilepsyAntiepileptic drugs and the risk of ischaemic stroke and myocardial infarction: a population-based cohort studyAssociation of LEPR and ANKK1 Gene Polymorphisms with Weight Gain in Epilepsy Patients Receiving Valproic Acid.The New Antiepileptic Drugs: Their Neuropharmacology and Clinical Indications.Effects of valproic acid on organic acid metabolism in children: a metabolic profiling studyDrug therapy of epileptic seizures among adult epileptic outpatients of University of Gondar Referral and Teaching Hospital, Gondar, North West Ethiopia.Weight gain following treatment with valproic acid: pathogenetic mechanisms and clinical implications.Central role of mitochondria in drug-induced liver injury.The long-term safety of antiepileptic drugs.Valproic acid and nonalcoholic fatty liver disease: A possible association?Drug-Induced Hyperglycaemia and Diabetes.Post-epilepsy stroke: A review.Does Valproic Acid Have Potential in the Treatment of Diabetes Mellitus?Diagnostic Yield and Accuracy of Different Metabolic Syndrome Criteria in Adult Patients with Epilepsy.Parameters of metabolic syndrome in Indian children with epilepsy on valproate or phenytoin monotherapy.Effect of antiepilepsy drug therapy on ventricular function in children with epilepsy: a tissue Doppler imaging study.Evaluation of Oral Glucose Tolerance Test in Children With Epilepsy.Improvement of oral contraceptive-induced glucose dysregulation and dyslipidemia by valproic acid is independent of circulating corticosterone.Insulin resistance in patients on valproic acid: relation to adiponectin.Assessment of atherosclerotic risk among patients with epilepsy on valproic acid, lamotrigine, and carbamazepine treatment.Weight and fat distribution in patients taking valproate: a valproate-discordant gender-matched twin and sibling pair study.Deterioration of metabolic parameters during short-term psychiatric inpatient treatment: a prospective naturalistic study.Characterization of glucose homeostasis and lipid profile in adult, seizure-free, epileptic patients in Asian population.
P2860
Q33718231-AB9A2991-D3B3-4CDF-80D9-81C3C75DFA5CQ33982437-6E90D2E2-AFC8-453E-96A1-8DCE900AA5F8Q34136014-7CF79142-B5F9-4C40-B55C-4F87C53F08DDQ35042426-8731C413-985F-4714-99AA-96C20D0E546FQ35427844-18C0004B-9E01-47A2-B62E-655C557B8D4EQ35960111-AC13989C-7F21-4F42-AB44-76FB00598C0FQ35965897-044494BD-CF71-4E75-B661-38943BEC79F6Q36909520-16120850-D941-4994-96DC-44156F3BB164Q37294747-8DE78ED0-4C24-4615-BEED-D89FBC290B70Q37538036-2BC069E9-8CE4-4954-8688-CAAAE6A8D336Q37794213-99779BD1-6CF8-4FAB-95AF-AC0E61937407Q37926590-ABCD2ED6-547B-4C24-B08B-CC0C72A6F2C3Q38106856-F3E502C2-8F57-49F4-BE18-3D1FEE47CC9CQ38505408-5A946507-1606-44A2-8522-EA787F91CAF9Q38586781-DEC4A1CA-B2CA-4412-93BE-46ADA1AC771CQ38751494-595EE88C-1186-42B3-9F81-78B5D608E347Q41049740-725B95E9-BB96-4A63-AD99-2614670C9BA0Q41237909-86167522-C01B-4D6B-B25E-9484E3B6E6B6Q43211870-D6B6F6BB-6FBC-4A3B-877B-E517A7B2E8C7Q43905937-DAB08AA8-6A52-4ACC-A958-0E366BB7C933Q44434068-A8524E7A-254E-441F-93CA-4167073A6AEAQ46218016-83F3BCAA-E8FB-4CD7-9F32-26408E43D63EQ46601959-F7847764-B6FC-4EC2-BB6D-910BB1492723Q47142337-EF2631FD-B133-45E1-9DF5-7DD384710ED0Q47442417-9D37D2B4-DDD1-4698-A809-0C9A002864F6Q50778364-B702AA60-58AE-479A-8BA0-AC515FCA56A5Q51358335-CC885579-6634-4798-A099-3E6119DB7D9B
P2860
The metabolic syndrome in overweight epileptic patients treated with valproic acid.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
The metabolic syndrome in overweight epileptic patients treated with valproic acid.
@en
The metabolic syndrome in overweight epileptic patients treated with valproic acid.
@nl
type
label
The metabolic syndrome in overweight epileptic patients treated with valproic acid.
@en
The metabolic syndrome in overweight epileptic patients treated with valproic acid.
@nl
prefLabel
The metabolic syndrome in overweight epileptic patients treated with valproic acid.
@en
The metabolic syndrome in overweight epileptic patients treated with valproic acid.
@nl
P2093
P1433
P1476
The metabolic syndrome in overweight epileptic patients treated with valproic acid.
@en
P2093
Alberto Verrotti
Francesco Chiarelli
Giangennaro Coppola
Rossella Manco
Sergio Agostinelli
P304
P356
10.1111/J.1528-1167.2009.02206.X
P577
2009-07-20T00:00:00Z